Dextera Surgical Inc. (NASDAQ:DXTR) shares traded down 1.8% on Tuesday . The stock traded as low as $0.25 and last traded at $0.26. 1,327,050 shares traded hands during trading, a decline of 68% from the average session volume of 4,155,850 shares. The stock had previously closed at $0.26.

Several research analysts have weighed in on the stock. Zacks Investment Research lowered shares of Dextera Surgical from a “buy” rating to a “hold” rating in a research note on Wednesday, August 9th. Ladenburg Thalmann Financial Services assumed coverage on shares of Dextera Surgical in a research report on Wednesday, August 16th. They set a “buy” rating and a $0.80 price target on the stock. Finally, Wedbush reduced their price target on shares of Dextera Surgical from $3.50 to $0.70 and set an “outperform” rating on the stock in a research report on Wednesday, July 12th.

The firm’s market cap is $4.60 million. The stock has a 50 day moving average of $0.30 and a 200 day moving average of $0.44.

Dextera Surgical (NASDAQ:DXTR) last posted its quarterly earnings results on Tuesday, August 8th. The medical instruments supplier reported ($0.40) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.29). The business had revenue of $1.05 million during the quarter, compared to the consensus estimate of $1.03 million. Equities analysts expect that Dextera Surgical Inc. will post ($0.24) EPS for the current fiscal year.

Several large investors have recently modified their holdings of DXTR. Perkins Capital Management Inc. purchased a new stake in shares of Dextera Surgical during the 2nd quarter worth about $100,000. Virtu KCG Holdings LLC grew its holdings in shares of Dextera Surgical by 1,380.6% during the 2nd quarter. Virtu KCG Holdings LLC now owns 369,918 shares of the medical instruments supplier’s stock worth $111,000 after purchasing an additional 344,933 shares during the period. Finally, Broadfin Capital LLC grew its holdings in shares of Dextera Surgical by 64.7% during the 2nd quarter. Broadfin Capital LLC now owns 987,520 shares of the medical instruments supplier’s stock worth $296,000 after purchasing an additional 388,080 shares during the period. Institutional investors and hedge funds own 6.58% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/10/05/dextera-surgical-inc-dxtr-shares-down-1-8.html.

Dextera Surgical Company Profile

Dextera Surgical Inc, formerly Cardica, Inc, designs and manufactures stapling devices that enable the advancement of minimally invasive surgical procedures. The Company is engaged in commercializing and developing its MicroCutter 5/80 stapler based on its staple-on-a-strip technology for use by thoracic, pediatric, bariatric, colorectal and general surgeons.

Receive News & Stock Ratings for Dextera Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dextera Surgical Inc. and related stocks with our FREE daily email newsletter.